An Open Label Study to Measure Efficacy of Fesoterodine (Toviaz) Post Surgery for Benign Prostatic Hyperplasia
Completed
Pfizer
Phase 4
2010-01-01
The subjects who have symptoms of overactive bladder (many trips to the bathroom, and urgency
with or without the inability to hold your urine until you get to the toilet) are invited to
participate in this research study.
An Open Label Study to Measure Efficacy of Fesoterodine (Toviaz) Post Surgery for Benign Prostatic Hyperplasia
Completed
Weill Medical College of Cornell University
Phase 4
2010-01-01
The subjects who have symptoms of overactive bladder (many trips to the bathroom, and urgency
with or without the inability to hold your urine until you get to the toilet) are invited to
participate in this research study.
Study In Patients With Overactive Bladder Treated With Toviaz® After Failure Of Previous Therapy
Completed
Pfizer
2008-07-01
This is a observational study in patients treated with fesoterodine (Toviaz), who have failed
on previous treatment for overactive bladder. It will collect epidemiological data and
investigate the efficacy and tolerability of fesoterodine.
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
